Healthspan Capital

?? Excited to announce the release of our LongBio Report 2025 -- comprehensively profiling the leading companies in longevity biotechnology. This is your guide to understanding the future of healthy lifespan extension. ?? Read the report:? https://lnkd.in/gPJcN9gF Why now? The convergence of breakthrough science in aging + accelerant technology (including AI) has sparked a new wave of startups. Visionaries are betting on longevity to be the next big thing: - Jeff Bezos ($3B // Altos) - Sam Altman ($180M // Retro Biosciences) - Brian Armstrong ($105M // NewLimit) Problem: The longevity field is noisy. It’s hard to separate the science from the snake oil. Our report dives deep into companies working on real therapeutic innovations – from mitochondrial transfer, cell reprogramming, replacement +more. We’ve broken down the landscape of longevity biotech across five core technological approaches: - Removal - Replacement - Reprogramming - Metabolic modulation - Non-specific Discovery Platforms? …and analyze key differentiators, funding, pipelines, foundational innovation of 46 leading companies in our report.? The longevity biotech sector represents one of the largest market opportunities of our time. With age-related diseases causing ~100,000 daily deaths worldwide + rapidly aging populations, the need for innovative therapeutic approaches has never been more urgent. ?? Whether you're from longevity, biotech, tech, or just curious about the future of aging - this is your roadmap to the field. ?? Read the LongBio Report 2025 here: https://lnkd.in/gPJcN9gF PS: We want to highlight Healthspan Capital venture fellow Alexander Tchernev for his incredible work in spearheading this report. Also want to thank all our friends, portfolio companies, and colleagues in the industry who provided valuable input and feedback.???